| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0615-8497-39 | 0615-8497 | HUMAN PRESCRIPTION DRUG | Loperamide Hydrochloride | Loperamide Hydrochloride | CAPSULE | ORAL | 20240112 | N/A | ANDA | ANDA216876 | NCS HealthCare of KY, LLC dba Vangard Labs | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 30 CAPSULE in 1 BLISTER PACK (0615-8497-39) |
| 72888-130-00 | 72888-130 | HUMAN PRESCRIPTION DRUG | Loperamide Hydrochloride | Loperamide Hydrochloride | CAPSULE | ORAL | 20230126 | N/A | ANDA | ANDA216876 | Advagen Pharma Ltd., | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 1000 CAPSULE in 1 BOTTLE (72888-130-00) |
| 72888-130-01 | 72888-130 | HUMAN PRESCRIPTION DRUG | Loperamide Hydrochloride | Loperamide Hydrochloride | CAPSULE | ORAL | 20230126 | N/A | ANDA | ANDA216876 | Advagen Pharma Ltd., | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 100 CAPSULE in 1 BOTTLE (72888-130-01) |
| 72888-130-05 | 72888-130 | HUMAN PRESCRIPTION DRUG | Loperamide Hydrochloride | Loperamide Hydrochloride | CAPSULE | ORAL | 20230126 | N/A | ANDA | ANDA216876 | Advagen Pharma Ltd., | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 500 CAPSULE in 1 BOTTLE (72888-130-05) |
| 72888-130-30 | 72888-130 | HUMAN PRESCRIPTION DRUG | Loperamide Hydrochloride | Loperamide Hydrochloride | CAPSULE | ORAL | 20230126 | N/A | ANDA | ANDA216876 | Advagen Pharma Ltd., | LOPERAMIDE HYDROCHLORIDE | 2 mg/1 | 30 CAPSULE in 1 BOTTLE (72888-130-30) |